Condition: Healthy Volunteer · Older Adults (65-85 Years) · Sponsor: University of Colorado, Denver
This study plans to learn more about the safety and tolerability of psychedelic administration (psilocybin) in healthy older adults ages 65-85.
This description comes directly from the study's public registry record.
Mary P Mancuso, MA (dual degrees) · 3037245729 · inspire@cuanschutz.edu
Lila Harris, BS · lila.m.harris@cuanschutz.edu
Always discuss trial participation with your own doctor first.
| University of California San Francisco (UCSF) Department of Neurology | San Francisco, California, United States | Recruiting |
| University of Colorado Anschutz Medical Campus | Aurora, Colorado, United States | Recruiting |
| Emory University Brain Health Center | Atlanta, Georgia, United States | Recruiting |
| Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
| University of Nebraska Medical Center | Omaha, Nebraska, United States | Not Yet Recruiting |
| New York University Langone Health, Center for Psychedelic Medicine | New York, New York, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07516405